Company: VEEAW
Filing Date: 2025-11-10
Form Type: PRE 14A
Source: 0001213900-25-107934
Chunk: 44

Company: VEEA INC.
Filing Date: 2025-11-10
Form: PRE 14A
Chunk 44
---
 |   |
| 5% Stockholders                                                  |     |                                        |            |     |   |      |   |
| NLabs Inc. (2)                                                   |     |                                        | 19,388,017 |     |   | 38.7 | % |
| Crowdkeep Inc.                                                   |     |                                        |  4,065,689 |     |   |  8.1 | % |
| Salmasi 2004 Trust                                               |     |                                        |  2,808,475 |     |   |  5.6 | % |
| Ursula Burns (10)                                                |     |                                        |  2,071,207 |     |   |  4.1 | % |
| Mike Dinsdale (12)                                               |     |                                        |  2,477,302 |     |   |  4.9 | % |
| All directors and executive officers as a group (10 individuals) |     |                                        | 28,440,658 |     |   | 56.8 | % |

| * | Less     
 than 1%. |

| 1) | Unless                                                                                                                            
 otherwise noted, the business address of each of the following entities or individuals is 164 E. 83rd Street, New York, New York, 
 United States.                                                                                                                    |

29

| 2) | Consists of 17,388,017 shares held by NLabs Inc., an entity controlled by Mr. Salmasi and members of his immediate family, 2,808,475 shares held by Salmasi 2004 Trust, the trustee of which is a member of Mr. Salmasi’s immediate family, 437,029 shares held directly by Mr. Salmasi, 491,059 shares held by Mr. Salmasi’s spouse, options to purchase 2,992,475 shares of common stock, and common warrants held by NLabs to purchase 2,000,000 shares of common stock. |

| 3) | Includes                           
 options to purchase 66,890 shares. |

| 4) | Includes                          
 option to purchase 60,200 shares. |

| 5) | Includes                                                                                                                            
 options to purchase 68,924 shares and excludes the options to purchase 125,000 shares that are subject to certain vesting schedules 
 including shareholder approval and certain revenue target of the company.                                                           |

| 6) | Includes                           
 options to purchase